4.7 Review

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway

Hang Yin et al.

Summary: This study reveals that m6A RNA methylation-mediated RMRP stability promotes proliferation and progression of non-small cell lung cancer through regulating the TGFBR1/SMAD2/SMAD3 pathway.

CELL DEATH AND DIFFERENTIATION (2023)

Article Gastroenterology & Hepatology

N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer

Shiyan Wang et al.

Summary: The study identified a novel oncogenic epitranscriptome axis of YTHDF1-m(6)A-ARHGEF2 that regulates CRC tumorigenesis and metastasis.

GASTROENTEROLOGY (2022)

Article Biotechnology & Applied Microbiology

FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner

Aoshuang Xu et al.

Summary: This study reveals the role of N-6-methyladenosine (m(6)A) in multiple myeloma (MM) pathogenesis and identifies fat mass and obesity-associated protein (FTO) as a crucial regulator. FTO plays a tumor-promoting and pro-metastatic role in MM through targeting heat shock factor 1 (HSF1)/heat shock proteins (HSPs) in a YTHDF2-dependent manner. The inhibition of FTO, especially in combination with bortezomib (BTZ) treatment, shows synergistic effects in inhibiting myeloma bone tumor formation and extramedullary spread. The study suggests FTO-HSF1/HSP axis as a potential therapeutic target in MM.

MOLECULAR THERAPY (2022)

Article Biochemistry & Molecular Biology

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways

Jianwei Qu et al.

Summary: In this study, it was found that RNA demethylase ALKBH5 was overexpressed in multiple myeloma patients and knocking down ALKBH5 induced apoptosis and inhibited MM cell growth. Mechanistic studies revealed that ALKBH5 exerted tumorigenic effects in myeloma in an m(6)A-dependent manner.

ONCOGENE (2022)

Article Chemistry, Multidisciplinary

Glutathione-Bioimprinted Nanoparticles Targeting of N6-methyladenosine FTO Demethylase as a Strategy against Leukemic Stem Cells

Kunxia Cao et al.

Summary: In this study, FTO inhibitor-loaded GSH-bioimprinted nanocomposites were developed to selectively target leukemia cells, especially leukemia stem cells (LSCs), and induce cell death by disrupting intracellular redox status. Additionally, the nanocomposites increased m(6)A RNA modification levels and enhanced the efficacy of immune therapy.

SMALL (2022)

Article Oncology

LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability

Yiran Zhu et al.

Summary: This study reveals the role of LNC942 in promoting chemoresistance in gastric cancer (GC) and suggests that disrupting the LNC942-MSI2-c-Myc axis could be a potential therapeutic strategy for GC patients with chemoresistance.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Article Oncology

RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

Xiangli Liu et al.

Summary: This study discovered that the m(6)A demethylase ALKBH5 is highly expressed in CSCs derived from non-small-cell lung cancer (NSCLC). Knockdown of ALKBH5 increased global m(6)A level and inhibited stemness of CSCs. Additionally, p53 transcriptionally regulated ALKBH5 and CSCs' malignancies, and also regulated PRRX1. These findings highlight the pivotal role of ALKBH5 in NSCLC-derived CSCs and the regulatory function of the p53/ALKBH5 axis in modulating CSC progression.

FRONTIERS IN ONCOLOGY (2022)

Article Hematology

piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL

Huiying Han et al.

Summary: The study demonstrates that piRNA-30473 plays an oncogenic role in promoting the aggressive phenotype of DLBCL, and its depletion can reduce proliferation and induce cell cycle arrest. Through regulating m6A RNA methylation, the piRNA-30473/WTAP/HK2 axis contributes to the progression of DLBCL.

BLOOD (2021)

Article Cell Biology

Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells

Fei Peng et al.

Summary: RNase III DROSHA is upregulated in various cancers and interacts with beta-Catenin to activate STC1 in a RNA cleavage-independent manner. The enhanced stability of DROSHA mRNA through m(6)A modification in BCSCs, activated by AURKA, plays a key role in promoting the BCSC phenotype. Inhibition of DROSHA m(6)A modification attenuates BCSC traits, highlighting the importance of AURKA-induced m(6)A modification in breast cancer progression.

CELL RESEARCH (2021)

Article Biochemistry & Molecular Biology

MYC promotes cancer progression by modulating m6A modifications to suppress target gene translation

Gongwei Wu et al.

Summary: The oncogene MYC promotes cancer progression by down-regulating N6-methyladenosine (m(6)A) modification preferentially in transcripts of MYC-repressed genes (MRGs). This alteration leads to the activation of ALKBH5 expression and reduction of m(6)A levels in specific MRGs, controlling their translation through the m(6)A reader YTHDF3. Ultimately, inhibiting ALKBH5 or overexpressing SPI1 or PHF12 effectively suppresses the growth of MYC-deregulated B-cell lymphomas.

EMBO REPORTS (2021)

Article Biochemistry & Molecular Biology

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis

Ying Qing et al.

Summary: R-2-hydroxyglutarate (R-2HG) inhibits aerobic glycolysis in leukemia cells by targeting RNA modification, highlighting the therapeutic potential of targeting cancer epitranscriptomics and metabolism. This study reveals previously unrecognized effects of R-2HG on leukemia cells, providing insights into novel treatments for cancer.

MOLECULAR CELL (2021)

Article Gastroenterology & Hepatology

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target

Huarong Chen et al.

Summary: The study revealed that the m(6)A regulatory enzyme METTL3 is upregulated in colorectal cancer (CRC) and predicts poor survival in patients. Inhibition of METTL3 suppresses tumorigenesis in CRC cells and organoids. METTL3 promotes CRC development by activating the m(6)A-GLUT1-mTORC1 axis.

GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

N6-methyladenosine (m6A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells

Kang-Xuan Jin et al.

Summary: This study investigates the impact of m(6)A deposition on mRNA on the fate of pluripotent stem cells, revealing that it regulates cell fate through modulation of mRNA stability. The results show that m(6)A depletion activates pErk and pAkt signaling pathways, affecting both the maintenance of pluripotency and lineage commitment decisions.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2

Xia Wang et al.

Summary: Studies have shown that RALYL, a liver progenitor specific gene, regulates HCC stemness by sustaining TGF-beta 2 mRNA stability, which may inspire precise therapeutic strategies for HCC.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia

Eliza Yankova et al.

Summary: The study identified a highly potent and selective catalytic inhibitor of METTL3, STM2457, which shows potential therapeutic value in treating AML. Treatment with this inhibitor leads to reduced AML growth, increased differentiation and apoptosis, and decreased m(6)A levels on leukemogenic mRNAs. In vivo pharmacological inhibition of METTL3 results in impaired engraftment and prolonged survival in mouse models of AML.

NATURE (2021)

Article Oncology

AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation

Xinyu Bian et al.

Summary: In hepatocellular carcinoma (HCC), high levels of AMD1 promote stemness in HCC cells through specific mechanisms, exacerbating the progression of HCC. Therefore, AMD1 holds promise as both a prognostic predictor and therapeutic target for HCC.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Hematology

A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication

Yue Sheng et al.

Summary: YTHDC1 functions as a nuclear m(6)A reader in RNA metabolism regulation, with its overexpression shown in AML. Genetic deletion of Ythdc1 blocks AML development and maintenance, as well as LSCs self-renewal. YTHDC1 also plays a role in normal hematopoiesis and HSPC maintenance, with haploinsufficiency reducing LSCs self-renewal in vivo.

BLOOD (2021)

Article Oncology

N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation

Yuanming Cheng et al.

Summary: The study revealed the crucial role of m(6)A in myeloid leukemia, where it maintains cell survival and the undifferentiated state necessary for leukemia maintenance through the formation of nuclear YTHDC1-m(6)A condensates.

CANCER CELL (2021)

Article Biochemistry & Molecular Biology

IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma

Sha Song et al.

Summary: Epigenetic alterations, including RNA methylation imbalance regulated by IDH2 and FTO, may play a key role in the tumorigenesis and progression of multiple myeloma by activating the Wnt signaling pathway. IDH2 could serve as a potential therapeutic target and prognostic factor for MM.

ONCOGENE (2021)

Review Oncology

SOX2 in development and cancer biology

Daniel Novak et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Biochemistry & Molecular Biology

YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness

Bing Han et al.

EMBO REPORTS (2020)

Review Genetics & Heredity

Molecular Mechanisms Driving mRNA Degradation by m(6)A Modification

Yujin Lee et al.

TRENDS IN GENETICS (2020)

Article Cell Biology

Modulation of circRNA Metabolism by m6A Modification

Gaia Di Timoteo et al.

CELL REPORTS (2020)

Article Biochemistry & Molecular Biology

m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance

Tengfei Zhou et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

Endoribonucleolytic Cleavage of m6A-Containing RNAs by RNase P/MRP Complex

Ok Hyun Park et al.

MOLECULAR CELL (2019)

Article Biochemistry & Molecular Biology

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Rui Su et al.

Review Cell & Tissue Engineering

Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications

Shogo Matoba et al.

CELL STEM CELL (2018)

Article Biochemistry & Molecular Biology

N6-Methyladenosine Guides mRNA Alternative Translation during Integrated Stress Response

Jun Zhou et al.

MOLECULAR CELL (2018)

Article Biochemistry & Molecular Biology

Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal

Jing Wen et al.

MOLECULAR CELL (2018)

Article Multidisciplinary Sciences

The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency

Alessandro Bertero et al.

NATURE (2018)

Article Multidisciplinary Sciences

mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis

Junho Choe et al.

NATURE (2018)

Article Multidisciplinary Sciences

The m6A-methylase complex recruits TREX and regulates mRNA export

Simon Lesbirel et al.

SCIENTIFIC REPORTS (2018)

Review Biochemistry & Molecular Biology

Wnt signaling in cancer

T. Zhan et al.

ONCOGENE (2017)

Article Biochemistry & Molecular Biology

m6A Facilitates eIF4F-Independent mRNA Translation

Ryan A. Coots et al.

MOLECULAR CELL (2017)

Article Multidisciplinary Sciences

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control

Isaia Barbieri et al.

NATURE (2017)

Article Cell Biology

Extensive translation of circular RNAs driven by N6-methyladenosine

Yun Yang et al.

CELL RESEARCH (2017)

Review Oncology

The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells

Natalia Gawlik-Rzemieniewska et al.

CANCER BIOLOGY & THERAPY (2016)

Review Genetics & Heredity

ALKBHs-facilitated RNA modifications and de-modifications

Endalkachew A. Alemu et al.

DNA REPAIR (2016)

Article Biochemistry & Molecular Biology

Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing

Wen Xiao et al.

MOLECULAR CELL (2016)

Article Biochemistry & Molecular Biology

The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells

Shuibin Lin et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

m6A RNA methylation promotes XIST-mediated transcriptional repression

Deepak P. Patil et al.

NATURE (2016)

Review Cell Biology

A decade of transcription factor-mediated reprogramming to pluripotency

Kazutoshi Takahashi et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Editorial Material Biochemistry & Molecular Biology

N6-methyladenosine-encoded epitranscriptomics

Nian Liu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Multidisciplinary Sciences

Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA

Chuanzhao Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Editorial Material Biochemistry & Molecular Biology

N6-methyladenosine-encoded epitranscriptomics

Nian Liu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

5′ UTR m6A Promotes Cap-Independent Translation

Kate D. Meyer et al.

Article Biochemistry & Molecular Biology

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

Xiao Wang et al.

Article Cell & Tissue Engineering

m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency

Tong Chen et al.

CELL STEM CELL (2015)

Article

Review Cancer stem cells in haematological malignancies

Radoslaw Zagozdzon et al.

Wspolczesna Onkologia-Contemporary Oncology (2015)

Article Cell Biology

Induced Pluripotency and Epigenetic Reprogramming

Konrad Hochedlinger et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)

Article Cell & Tissue Engineering

m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells

Pedro J. Batista et al.

CELL STEM CELL (2014)

Article Multidisciplinary Sciences

N6-methyladenosine-dependent regulation of messenger RNA stability

Xiao Wang et al.

NATURE (2014)

Article Biochemistry & Molecular Biology

A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

Jianzhao Liu et al.

NATURE CHEMICAL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility

Guanqun Zheng et al.

MOLECULAR CELL (2013)

Article Multidisciplinary Sciences

Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds

Pingping Hou et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

Dan Dominissini et al.

NATURE (2012)

Review Biochemistry & Molecular Biology

Control of the Embryonic Stem Cell State

Richard A. Young

Article Biochemistry & Molecular Biology

N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

Guifang Jia et al.

NATURE CHEMICAL BIOLOGY (2011)

Review Oncology

Notch signalling in solid tumours: a little bit of everything but not all the time

Prathibha Ranganathan et al.

NATURE REVIEWS CANCER (2011)

Article Biotechnology & Applied Microbiology

Embryonic stem cell-specific microRNAs promote induced pluripotency

Robert L. Judson et al.

NATURE BIOTECHNOLOGY (2009)

Editorial Material Cell & Tissue Engineering

A combined chemical and genetic approach for the generation of induced pluripotent stem cells

Yan Shi et al.

CELL STEM CELL (2008)

Article Cell & Tissue Engineering

Module map of stem cell genes guides creation of epithelial cancer stem cells

David J. Wong et al.

CELL STEM CELL (2008)

Article Biotechnology & Applied Microbiology

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

Danwei Huangfu et al.

NATURE BIOTECHNOLOGY (2008)

Review Oncology

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Jane E. Visvader et al.

NATURE REVIEWS CANCER (2008)

Article Biochemistry & Molecular Biology

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Kazutoshi Takahashi et al.